Skip to main content
Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
5.23
-0.53 (-9.20%)
At close: Apr 28, 2026, 4:00 PM EDT
5.32
+0.09 (1.72%)
After-hours: Apr 28, 2026, 7:24 PM EDT

Immuneering Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
53
Market Cap
338.37M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022316.95K-1.76M-84.76%
Dec 31, 20212.08M-231.57K-10.02%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
X4 Pharmaceuticals 35.11M
Opus Genetics 14.20M
Armata Pharmaceuticals 4.90M
Surrozen 3.48M
Compass Therapeutics 850.00K
Silence Therapeutics 559.00K
YD Bio 510.36K
Avalo Therapeutics 59.00K
Revenue Rankings

IMRX News

More News